-
Moody's To Benefit From M&A Activity Recovery, Margins Expansion, Analysts Say
Thursday, October 23, 2025 - 11:52am | 372Read More...Moody’s Corp (NYSE:MCO) reported solid third-quarter results on Wednesday. Here are some key analyst takeaways: Stifel analyst Shlomo Rosenbaum maintained a Hold rating, while reducing the price target from $526 to $471. RBC Capital Markets analyst Ashish Sabadra reiterated an Outperform...
-
NIQ Global Intelligence Targets $57 Billion Market As Analysts Highlight AI, Margins
Monday, August 18, 2025 - 11:58am | 501Read More...As the market for consumer data analytics continues to expand, companies like NIQ Global Intelligence PLC (NYSE:NIQ) are positioning themselves to capitalize on growing demand. This trend has caught the attention of analysts who are now beginning to offer their insights on NIQ after the company...
-
McGraw Hill Transitions To Digital As Analyst Highlights 'Recession-Resistant Business'
Monday, August 18, 2025 - 10:59am | 470Read More...As the education sector increasingly turns towards digital solutions, companies that adapt swiftly are poised to capture significant market share. McGraw Hill Inc. (NYSE:MH) , a longstanding name in educational publishing, is making strategic moves to redefine its place in this evolving landscape....
-
Cintas Trades Higher After Q1 Print: 3 Takes From The Street
Wednesday, September 25, 2019 - 2:56pm | 608Read More...Workplace uniform maker Cintas Corporation (NASDAQ: CTAS) reported first-quarter results Tuesday that were interpreted differently by three Street analysts. The Analysts Stifel analyst Shlomo Rosenbaum maintained a Hold rating on Cintas with a price target lifted from $226 to $256. Credit...
-
Brightview Holdings Has 14% Upside Potential, Stifel Says In Bullish Initiation
Monday, July 23, 2018 - 3:01pm | 405Read More...Brightview Holdings Inc (NYSE: BV) is an appropriate stock for investors who can accept moderate returns in in the face of moderate risk, according to Stifel. The Analyst Stifel's Shlomo Rosenbaum initiated coverage of Brightview with a Buy rating and $25 price target. The Thesis...
-
Why Are Analysts Jumping Into TransUnion?
Tuesday, August 4, 2015 - 10:48am | 487Read More...In separate reports published Tuesday, analysts at both Stifel and Deutsche Bank initiated coverage of TransUnion (NYSE: TRU) with Buy ratings. Stifel: Strong Top And Bottom-Line Growth Shlomo Rosenbaum of Stifel initiated coverage of TransUnion at Buy with a $29 price target as the company...
-
UPDATE: Stifel Upgrades The Advisory Board Company As Royall Acquisition Enhances Growth
Thursday, December 11, 2014 - 8:54am | 220Read More...In a report published Thursday, Stifel analyst Shlomo Rosenbaum upgraded the rating on The Advisory Board Company (NASDAQ: ABCO) from Hold to Buy, and named a $47.00 price target. In the report, Stifel noted, “We are upgrading our rating on ABCO shares from Hold to Buy post the announcement of the...
-
UPDATE: Stifel Downgrades The Advisory Board On Shaky Value Drivers
Friday, November 7, 2014 - 9:14am | 184Read More...In a report published Friday, Stifel analyst Shlomo Rosenbaum downgraded the rating on The Advisory Board Company (NASDAQ: ABCO) from Buy to Hold, but reiterated the $65.00 price target. In the report, Stifel noted, “We are lowering our rating on the shares of ABCO from Buy to Hold following F2Q15...
-
UPDATE: Stifel Initiates Coverage On IMS Health On Current Valuation Metrics
Wednesday, May 14, 2014 - 8:26am | 121Read More...In a report published Wednesday, Stifel analyst Shlomo Rosenbaum initiated coverage on IMS Health (NYSE: IMS) with a Buy rating and $29.00 price target. In the report, Stifel noted, “We are initiating coverage of IMS Health Holdings, Inc. (IMS) with a Buy rating on the shares. Our $29 target price...
-
UPDATE: Stifel Initiates Coverage on IHS on Fair Valuation
Tuesday, December 17, 2013 - 9:26am | 107Read More...In a report published Tuesday, Stifel analyst Shlomo Rosenbaum initiated coverage on IHS (NYSE: IHS) with a Hold rating. In the report, Stifel noted, “We are initiating coverage of IHS Inc. with a Hold, or neutral, rating on the shares based on valuation in the context of expected growth. We are...
-
UPDATE: Stifel Reiterates on Stericycle Following Revenue/EPS Miss, Unchanged Business Outlook
Thursday, October 24, 2013 - 9:02am | 228Read More...In a report published Thursday, Stifel analyst Shlomo Rosenbaum reiterated a Buy rating on Stericycle (NASDAQ: SRCL), and raised the price target from $123.00 to $138.00. In the report, Stifel noted, “Although revenue and EPS (normalizing for low tax rate) were lower than expected, and organic...
-
UPDATE: Stifel Nicolaus Raises PT on Advisory Board Company on Continued Solid Growth, Market Expansion
Thursday, August 1, 2013 - 10:30am | 193Read More...In a report published Thursday, Stifel Nicolaus analyst Shlomo Rosenbaum reiterated a Buy rating on Advisory Board Company (NASDAQ: ABCO), and raised the price target from $58.00 to $68.00. In the report, Stifel Nicolaus noted, “ABCO reported solid numbers in our view, and we believe the YOY CV...
-
UPDATE: Stifel Nicolaus Downgrades Iron Mountain to Hold on Less Likely REIT Conversion
Friday, June 7, 2013 - 11:17am | 173Read More...In a report published Friday, Stifel Nicolaus analyst Shlomo Rosenbaum downgraded the rating Iron Mountain (NYSE: IRM) from Buy to Hold and removed the $42.00 price target. In the report, Stifel Nicolaus noted, “We are lowering our rating on the IRM shares from Buy to Hold since we believe the...
